Last $167.06 USD
Change Today +1.72 / 1.04%
Volume 393.2K
IDXX On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 01/23/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for idexx laboratories inc (IDXX)

Although debt as a percent of total capital increased at IDEXX Laboratories, Inc. over the last fiscal year to 45.36%, it is still in-line with the Healthcare Equipment and Supplies industry's norm. Additionally, even though there are not enough liquid assets to satisfy current obligations, Operating Profits are more than adequate to service the debt. Accounts Receivable are among the industry's worst, with 39.28 days worth of sales outstanding. This implies that, although the trend is improving, revenues are not being collected in an efficient manner. Last, IDEXX Laboratories, Inc. is among the least efficient in its industry at managing inventories, but it is getting better, with 80.64 days of its Cost of Goods Sold tied up in Inventories.
Currency in
Millions of US Dollars
As of:Dec 31
2010
Dec 31
2011
Restated
Dec 31
2012
Restated
Dec 31
2013
4 Year
Trend
Assets    
Cash and Equivalents156.9183.9224.0279.1
TOTAL CASH AND SHORT TERM INVESTMENTS156.9183.9224.0279.1
TOTAL RECEIVABLES120.1141.3138.3158.0
Deferred Tax Assets, Current26.225.627.733.2
TOTAL CURRENT ASSETS460.6524.2569.5652.7
Gross Property Plant and Equipment376.6422.4478.3550.0
Accumulated Depreciation-174.9-205.6-233.1-268.8
NET PROPERTY PLANT AND EQUIPMENT201.7216.8245.2281.2
Goodwill149.1172.6175.0180.5
Deferred Charges, Long Term5.521.121.821.2
Other Long-Term Assets24.526.929.336.0
TOTAL ASSETS897.11,030.81,103.61,230.5
    
LIABILITIES & EQUITY    
Accrued Expenses106.3122.3120.1130.6
Current Income Taxes Payable12.317.714.916.5
Unearned Revenue, Current14.015.020.221.5
TOTAL CURRENT LIABILITIES285.1436.9406.3478.4
Long-Term Debt3.42.51.4150.4
Unearned Revenue, Non-Current4.610.812.718.4
Deferred Tax Liability Non-Current18.723.323.033.9
Other Non-Current Liabilities11.017.723.931.2
Common Stock9.89.910.010.1
Additional Paid in Capital641.6702.6757.2825.3
Retained Earnings965.51,127.31,305.61,493.4
Treasury Stock-1,060.6-1,320.4-1,457.2-1,829.4
TOTAL COMMON EQUITY574.2539.6636.2518.2
TOTAL EQUITY574.3539.6636.3518.2
TOTAL LIABILITIES AND EQUITY897.11,030.81,103.61,230.5
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IDXX:US $167.06 USD +1.72

IDXX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
DENTSPLY International Inc $50.89 USD +0.01
Hologic Inc $29.35 USD -0.165
Mettler-Toledo International Inc $303.05 USD -1.72
ResMed Inc $65.24 USD +3.38
Cooper Cos Inc/The $161.75 USD -2.35
View Industry Companies
 

Industry Analysis

IDXX

Industry Average

Valuation IDXX Industry Range
Price/Earnings 43.5x
Price/Sales 5.6x
Price/Book 35.2x
Price/Cash Flow 40.0x
TEV/Sales 4.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IDEXX LABORATORIES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.